Internal Medicine, Rheumatology · State College, PA
NPI
1194904797
Since 2007
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
2520 Green Tech Dr
State College, PA, 16803
Phone (814) 231-4560
Groups this clinician bills Medicare through
Medicare paid, 2024
$579K
71,264 services
Medicare patients, 2024
1,761
Average age 74
Drug cost, 2024
$6.5M
5,860 prescriptions
Company payments, 2025
$148
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Brian P Oppermann was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 47,500 times for 15 patients. In total Brian P Oppermann billed 71,264 services in 26 codes, and Medicare paid $579K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-06-16.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 47,500 | 15 | $3.60 | $171K |
| J0897 Injection, denosumab, 1 mg | Office | 13,680 | 156 | $20.37 | $279K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 2,740 | 43 | $0.10 | $264 |
| 77080 Standard X-ray | Facility | 713 | 712 | $8.88 | $6,330 |
| 96372 Injection Administration | Office | 472 | 181 | $10.16 | $4,795 |
| 99214 Office E&M - Established | Office | 402 | 372 | $79.34 | $32K |
| 77080 Standard X-ray | Office | 398 | 398 | $35.59 | $14K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 268 | 257 | $11.93 | $3,196 |
| 77092 Standard X-ray | Facility | 253 | 253 | $6.09 | $1,542 |
| 99213 Office E&M - Established | Office | 213 | 209 | $56.41 | $12K |
| 77089 Standard X-ray | Office | 127 | 127 | $24.89 | $3,161 |
| 99204 Office E&M - New | Office | 83 | 83 | $108.53 | $9,008 |
| J1020 Injection, methylprednisolone acetate, 20 mg | Office | 54 | 21 | $2.35 | $127 |
| 20610 Joint Injection | Office | 52 | 28 | $49.12 | $2,554 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 28 | 28 | $10.71 | $300 |
By year: 2022 $324K for 40,427 services; 2023 $548K for 62,373 services; 2024 $579K for 71,264 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 24 | 19 | $2.96 | $70.95 |
Medicare prescription drug claims, 2024
In 2024, the drug Brian P Oppermann prescribed most often to Medicare patients was Prednisone, with 1,078 prescriptions and refills. In total Brian P Oppermann wrote 5,860 Medicare prescriptions that cost $6.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 1,078 | 2,193 | 331 | $9,888 |
| Methotrexate Methotrexate Sodium | 770 | 1,750 | 222 | $26K |
| Hydroxychloroquine Sulfate Generic | 514 | 1,219 | 160 | $22K |
| Alendronate Sodium Generic | 313 | 572 | 75 | $2,398 |
| Allopurinol Generic | 276 | 636 | 72 | $4,816 |
| Enbrel Sureclick Etanercept | 193 | 207 | 23 | $1.5M |
| Leflunomide Generic | 175 | 369 | 53 | $12K |
| Celecoxib Generic | 159 | 353 | 55 | $4,887 |
| Methylprednisolone Generic | 144 | 182 | 58 | $1,912 |
| Tramadol Hcl Generic | 140 | 140 | 29 | $902 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 135 | 136 | 21 | $1,706 |
| Humira Pen Adalimumab | 131 | 136 | 20 | $923K |
| Gabapentin Generic | 114 | 253 | 34 | $2,468 |
| Duloxetine Hcl Generic | 89 | 228 | 25 | $1,986 |
| Risedronate Sodium Generic | 88 | 188 | 22 | $5,245 |
Brand drugs: 1,121 claims; generic drugs: 4,725 claims; opioid claims: 471.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Brian P Oppermann $148 ($148 in general payments such as food, travel and fees) from 1 company. The largest payer was AstraZeneca Pharmaceuticals LP with $148.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 9 | $148 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.